34856436|t|The metabolic signaling of the nucleoredoxin-like 2 gene supports brain function.
34856436|a|The nucleoredoxin gene NXNL2 encodes for two products through alternative splicing, rod-derived cone viability factor-2 (RdCVF2) that mediates neuronal survival and the thioredoxin-related protein (RdCVF2L), an enzyme that regulates the phosphorylation of TAU. To investigate the link between NXNL2 and tauopathies, we studied the Nxnl2 knockout mouse (Nxnl2-/-). We established the expression pattern of the Nxnl2 gene in the brain using a Nxnl2 reporter mouse line, and characterized the behavior of the Nxnl2-/- mouse at 2 months of age. Additionally, long term potentiation and metabolomic from hippocampal specimens were collected at 2 months of age. We studied TAU oligomerization, phosphorylation and aggregation in Nxnl2-/- brain at 18 months of age. Finally, newborn Nxnl2-/- mice were treated with adeno-associated viral vectors encoding for RdCVF2, RdCVF2L or both and measured the effect of this therapy on long-term potential, glucose metabolism and late-onset tauopathy. Nxnl2-/- mice at 2 months of age showed severe behavioral deficiency in fear, pain sensitivity, coordination, learning and memory. The Nxnl2-/- also showed deficits in long-term potentiation, demonstrating that the Nxnl2 gene is involved in regulating brain functions. Dual delivery of RdCVF2 and RdCVF2L in newborn Nxnl2-/- mice fully correct long-term potentiation through their synergistic action. The expression pattern of the Nxnl2 gene in the brain shows a predominant expression in circumventricular organs, such as the area postrema. Glucose metabolism of the hippocampus of Nxnl2-/- mice at 2 months of age was reduced, and was not corrected by gene therapy. At 18-month-old Nxnl2-/- mice showed brain stigmas of tauopathy, such as oligomerization, phosphorylation and aggregation of TAU. This late-onset tauopathy can be prevented, albeit with modest efficacy, by recombinant AAVs administrated to newborn mice. The Nxnl2-/- mice have memory dysfunction at 2-months that resembles mild-cognitive impairment and at 18-months exhibit tauopathy, resembling to the progression of Alzheimer's disease. We propose the Nxnl2-/- mouse is a model to study multistage aged related neurodegenerative diseases. The NXNL2 metabolic and redox signaling is a new area of therapeutic research in neurodegenerative diseases.
34856436	31	51	nucleoredoxin-like 2	Gene	75124
34856436	86	99	nucleoredoxin	Gene	18230
34856436	105	110	NXNL2	Gene	75124
34856436	166	201	rod-derived cone viability factor-2	Gene	75124
34856436	203	209	RdCVF2	Gene	75124
34856436	251	278	thioredoxin-related protein	Gene	53382
34856436	375	380	NXNL2	Gene	75124
34856436	385	396	tauopathies	Disease	MESH:D024801
34856436	413	418	Nxnl2	Gene	75124
34856436	428	433	mouse	Species	10090
34856436	435	440	Nxnl2	Gene	75124
34856436	491	496	Nxnl2	Gene	75124
34856436	523	528	Nxnl2	Gene	75124
34856436	538	543	mouse	Species	10090
34856436	588	593	Nxnl2	Gene	75124
34856436	597	602	mouse	Species	10090
34856436	805	810	Nxnl2	Gene	75124
34856436	858	863	Nxnl2	Gene	75124
34856436	867	871	mice	Species	10090
34856436	934	940	RdCVF2	Gene	75124
34856436	1022	1029	glucose	Chemical	MESH:D005947
34856436	1056	1065	tauopathy	Disease	MESH:D024801
34856436	1067	1072	Nxnl2	Gene	75124
34856436	1076	1080	mice	Species	10090
34856436	1114	1135	behavioral deficiency	Disease	MESH:D001523
34856436	1145	1161	pain sensitivity	Disease	MESH:D010146
34856436	1202	1207	Nxnl2	Gene	75124
34856436	1282	1287	Nxnl2	Gene	75124
34856436	1353	1359	RdCVF2	Gene	75124
34856436	1383	1388	Nxnl2	Gene	75124
34856436	1392	1396	mice	Species	10090
34856436	1498	1503	Nxnl2	Gene	75124
34856436	1609	1616	Glucose	Chemical	MESH:D005947
34856436	1650	1655	Nxnl2	Gene	75124
34856436	1659	1663	mice	Species	10090
34856436	1751	1756	Nxnl2	Gene	75124
34856436	1760	1764	mice	Species	10090
34856436	1772	1785	brain stigmas	Disease	MESH:D001927
34856436	1789	1798	tauopathy	Disease	MESH:D024801
34856436	1881	1890	tauopathy	Disease	MESH:D024801
34856436	1983	1987	mice	Species	10090
34856436	1993	1998	Nxnl2	Gene	75124
34856436	2002	2006	mice	Species	10090
34856436	2012	2030	memory dysfunction	Disease	MESH:D008569
34856436	2063	2083	cognitive impairment	Disease	MESH:D003072
34856436	2109	2118	tauopathy	Disease	MESH:D024801
34856436	2153	2172	Alzheimer's disease	Disease	MESH:D000544
34856436	2189	2194	Nxnl2	Gene	75124
34856436	2198	2203	mouse	Species	10090
34856436	2248	2274	neurodegenerative diseases	Disease	MESH:D019636
34856436	2280	2285	NXNL2	Gene	75124
34856436	2357	2383	neurodegenerative diseases	Disease	MESH:D019636
34856436	Association	MESH:D010146	75124
34856436	Association	MESH:D001523	75124
34856436	Association	MESH:D003072	75124
34856436	Association	MESH:D005947	MESH:D024801
34856436	Association	MESH:D000544	75124
34856436	Association	MESH:D019636	75124
34856436	Association	MESH:D008569	75124
34856436	Association	MESH:D024801	75124
34856436	Association	MESH:D001927	75124

